Mineralys Therapeutics, Inc.
MLYS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$177,810 | -$71,898 | -$29,799 | -$19,408 |
| Dep. & Amort. | $43 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11,336 | $5,060 | $455 | $80 |
| Change in WC | $9,522 | -$7,470 | $772 | $4,085 |
| Other Non-Cash | -$9,405 | -$6,865 | -$649 | $684 |
| Operating Cash Flow | -$166,314 | -$81,173 | -$29,221 | -$14,559 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$96 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$373,445 | -$347,972 | -$71,759 | $0 |
| Inv. Sales/Matur. | $488,500 | $187,500 | $50,000 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $114,959 | -$160,472 | -$21,759 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $116,059 | $202,990 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$1,629 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $83 | $258 | $129,648 | $23,812 |
| Financing Cash Flow | $116,142 | $203,248 | $128,019 | $23,812 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $64,787 | -$38,397 | $77,039 | $9,253 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $49,304 | $87,701 | $10,662 | $1,409 |
| End Cash | $114,091 | $49,304 | $87,701 | $10,662 |
| Free Cash Flow | -$166,410 | -$81,173 | -$29,221 | -$14,559 |